Vitamin D and cardiovascular health

Lavie, Carl J., DiNicolantonio, James J., Milani, Richard V. and O’Keefe, James H. (2013) Vitamin D and cardiovascular health. Circulation, 128 22: 2404-2406. doi:10.1161/CIRCULATIONAHA.113.002902

Author Lavie, Carl J.
DiNicolantonio, James J.
Milani, Richard V.
O’Keefe, James H.
Title Vitamin D and cardiovascular health
Journal name Circulation   Check publisher's open access policy
ISSN 0009-7322
Publication date 2013-11
Year available 2013
Sub-type Article (original research)
DOI 10.1161/CIRCULATIONAHA.113.002902
Open Access Status
Volume 128
Issue 22
Start page 2404
End page 2406
Total pages 3
Place of publication Baltimore, United States
Publisher Lippincott Williams & Wilkins
Collection year 2014
Language eng
Formatted abstract
A 56-year-old black female patient with significant coronary heart disease (CHD) after several percutaneous intervention procedures for acute coronary syndromes was seen in the office for routine follow-up. She is 5 ft 5 in tall and weighs 265 pounds. She had recently gained 25 pounds after losing nearly 100 pounds following bariatric surgery. Her blood pressure, which was previously controlled with her therapy for hypertension, which included a β-blocker, an angiotensin-converting enzyme inhibitor, a calcium blocker, and a diuretic, was 160/90 mm Hg. Her fasting glucose was 168 mg/dL, with a hemoglobin A1C of 8.4% on therapy for type 2 diabetes mellitus. She was experiencing severe myalgias, which made it difficult for her to exercise, so she discontinued her atorvastatin. Her fasting lipid profile was as follows: total cholesterol, 264 mg/dL; high-density lipoprotein, 42 mg/dL; triglycerides, 220 mg/dL; and low-density lipoprotein, 178 mg/dL. Her 25-hydroxyvitamin D [25(OH)D] level was severely low at 8 ng/mL.

There have been several nutrient fads over recent decades, including beta carotene, selenium, folic acid, and vitamins E and C, all of which failed to show benefit in multiple large, randomized, controlled trials and thus did not stand the test of time, at least in terms of major cardiovascular event reduction.1,2 Without question, vitamin D increases absorption of calcium, magnesium, and phosphorus and mobilizes calcium and phosphorus from bone. It is also clear that vitamin D deficiency adversely affects the musculoskeletal system, predisposing to rickets in children and osteomalacia and osteoporosis in adults. The potential role of vitamin D in the pathogenesis of statin-induced myopathy and myalgias is debatable, although currently it appears reasonable to use vitamin D supplementation in patients with such symptoms, especially if they also have deficient or even mildly reduced vitamin D levels.3 Indeed, musculoskeletal pain is generally the first and most common subjective complaint in individuals who are vitamin D deficient.4
Q-Index Code CX
Q-Index Status Confirmed Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Article (original research)
Collections: Non HERDC
ERA White List Items
School of Medicine Publications
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 15 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 16 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Sun, 12 Jan 2014, 00:04:35 EST by System User on behalf of School of Medicine